Commission Actions

Refine your results

Commission Actions

Items per page

Buscar

Keyword

Filtros

Type

Fecha

Year must also be selected when searching by month.

Displaying 7361 - 7380 of 38052

Show:

22 de Feb de 2019

Para su Difusión

FTC Approves Final Order Imposing Conditions on Penn National Gaming, Inc.’s Acquisition of Pinnacle Entertainment, Inc.

Fecha

22 de Feb de 2019

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that casino operator Penn National Gaming, Inc.’s $2.8 billion agreement to acquire Pinnacle...

Cases and Proceedings

Closing Letters

3D Solutech, Inc.

Date

22 de Feb de 2019

Matter Number

P074204

Closing letter to Gabe Verdugo, Counsel for 3D Solutech, Inc. (508.17 KB)

Case Timeline Item

Watson Pharmaceuticals, Inc., et al. (FTC v. Actavis) (timeline item) - February 22, 2019

Date

22 de Feb de 2019

Stipulation and Order Dismissing with Prejudice as to Defendants Actavis, Inc. and Actavis Holdco US, Inc. (69.54 KB)

Exhibit A (Stipulated Revised Order for Permanent Injunction and Equitable Monetary Relief) (14.63 MB)

Case Timeline Item

Linde AG and Praxair, Inc., In the Matter of (timeline item) - February 22, 2019

Date

22 de Feb de 2019

Commission Letter Approving the Divestiture of Certain Gases Assets to LyondellBasell Acetyls (134.79 KB)

Case Timeline Item

Benco/Schein/Patterson, In the Matter of (timeline item) - February 22, 2019

Date

22 de Feb de 2019

Administrative Law Judge’s Order Denying Patterson's Motion to Dismiss (1.08 MB)

Case Timeline Item

Allergan, Watson and Endo (timeline item) - February 22, 2019

Date

22 de Feb de 2019

Notice of Voluntary Dismissal With Prejudice (32.81 KB)

Exhibit A (Stipulated Revised Order for Permanent Injunction and Equitable Monetary Relief) (14.62 MB)

Case Timeline Item

Penn National Gaming and Pinnacle Entertainment, In the Matter of (timeline item) - February 22, 2019

Date

22 de Feb de 2019

Complaint (24.79 KB)

Decision and Order (154.82 KB)

Letters to Commenter (46.86 KB)

21 de Feb de 2019

Para su Difusión

FTC Approves Final Consent Order against Company and Owner Who Allegedly Made Unsupported Health Claims for Intravenously Injected Therapy Products

Fecha

21 de Feb de 2019

Following a public comment period, the Federal Trade Commission has approved a final order settling charges against a Texas-based marketer and seller of intravenously injected therapy products (iV...

Case Timeline Item

A&O Enterprises, doing business as iV Bars, and Aaron K. Roberts, In the Matter of (timeline item) - February 21, 2019

Date

21 de Feb de 2019

Complaint (939.09 KB)

Exhibit A: Web Capture (9.69 MB)

Exhibit B: Release Form (111.62 KB)

Decision and Order (68.84 KB)

Letters to Commenters (157.52 KB)

Case Timeline Item

Quincy Bioscience Holding Company (timeline item) - February 21, 2019

Date

21 de Feb de 2019

Summary Order (2d Cir.) (571.91 KB)

Case Timeline Item

Benco/Schein/Patterson, In the Matter of (timeline item) - February 21, 2019

Date

21 de Feb de 2019

Administrative Law Judge’s Order On Respondents' In Camera Documents (6.58 MB)

Administrative Law Judge’s Order on Post-Trail Briefs (1.59 MB)

Administrative Law Judge’s Order Closing Hearing Record (165.62 KB)

19 de Feb de 2019

Cases and Proceedings

Commissioner Statements

Statement of Chairman Simons, Commissioner Phillips, and Commissioner Wilson Concerning the Proposed Acquisition of NxStage Medical, Inc. by Fresenius Medical Care AG & Co. KGaA

Date

19 de Feb de 2019

Joseph J. Simons, Former Chairman;

Noah Joshua Phillips, Former Commissioner;

Christine S. Wilson, Former Commissioner

Matter Number

171 0227

Statement of Chairman Simons, Commissioner Phillips, and Commissioner Wilson Concerning the Proposed Acquisition of NxStage Medical, Inc. by Fresenius Medical Care AG & Co. KGaA (21.81 KB)

Cases and Proceedings

Commissioner Statements

Statement of Commissioner Chopra In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc.

Date

19 de Feb de 2019

Rohit Chopra, Former Commissioner

Matter Number

171 0227

Statement of Commissioner Chopra In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc. (59.97 KB)

Cases and Proceedings

Commissioner Statements

Statement of Commissioner Slaughter In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc.

Date

19 de Feb de 2019

Rebecca Kelly Slaughter, Former Commissioner

Matter Number

171 0227

Statement of Commissioner Slaughter In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc. (47.96 KB)

Para su Difusión

FTC Requires Fresenius Medical Care AG & KGaA and NxStage Medical, Inc. to Divest Bloodline Tubing Assets to B. Braun Medical, Inc. as a Condition of Merger

Fecha

19 de Feb de 2019

The Federal Trade Commission will require healthcare companies Fresenius Medical Care AG & KGaA (Fresenius) and NxStage Medical, Inc. (NxStage) to divest all rights and assets related to NxStage’s...

Para su Difusión

FTC Enters Global Settlement to Resolve Reverse-Payment Charges against Teva

Fecha

19 de Feb de 2019

The Federal Trade Commission has reached a global settlement resolving pending claims in three separate federal court antitrust lawsuits involving subsidiaries of pharmaceutical manufacturer Teva...

Feb01

Evento